Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-10-15

Clinical Trial Update: Does Ascorbic Acid Reduce Sympathoexcitation in CHF? [NA]

View source ↗

Summary

A completed clinical trial from Radboud University Medical Center evaluated whether ascorbic acid reduces sympathoexcitation in heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ascorbic acid (Vitamin C)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Heart Failure | NA | Status: COMPLETED